Alfredo Rivas‐Delgado

1.8k total citations
27 papers, 464 citations indexed

About

Alfredo Rivas‐Delgado is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Alfredo Rivas‐Delgado has authored 27 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 9 papers in Genetics. Recurrent topics in Alfredo Rivas‐Delgado's work include Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Alfredo Rivas‐Delgado is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Alfredo Rivas‐Delgado collaborates with scholars based in Spain, Japan and United States. Alfredo Rivas‐Delgado's co-authors include Julio Delgado, Tycho Baumann, Elı́as Campo, Pablo Mozas, Laura Magnano, Eva Giné, Armando López‐Guillermo, Olga Balagué, Blanca González‐Farré and Neus Villamor and has published in prestigious journals such as Blood, Diabetes Care and Annals of Oncology.

In The Last Decade

Alfredo Rivas‐Delgado

25 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alfredo Rivas‐Delgado Spain	12	264	184	146	127	73	27	464
Sylvie Daliphard France	12	90 0.3×	97 0.5×	160 1.1×	118 0.9×	34 0.5×	27	489
Andrea Janíková Czechia	15	425 1.6×	378 2.1×	154 1.1×	105 0.8×	16 0.2×	81	699
Marie‐Paule Chauveheid France	14	148 0.6×	24 0.1×	112 0.8×	148 1.2×	69 0.9×	33	636
Georgios Paterakis Greece	10	94 0.4×	92 0.5×	96 0.7×	101 0.8×	13 0.2×	32	368
Masaharu Kohara Japan	11	134 0.5×	115 0.6×	49 0.3×	50 0.4×	88 1.2×	32	286
Greg Hapgood Australia	9	226 0.9×	123 0.7×	38 0.3×	55 0.4×	66 0.9×	28	390
Adam Ackerman United States	5	340 1.3×	226 1.2×	187 1.3×	24 0.2×	22 0.3×	8	491
Antonella Montanini Italy	9	354 1.3×	194 1.1×	82 0.6×	21 0.2×	34 0.5×	14	430
Myrto Costopoulos France	10	239 0.9×	49 0.3×	221 1.5×	36 0.3×	35 0.5×	22	531
C McClinton United Kingdom	11	62 0.2×	39 0.2×	61 0.4×	181 1.4×	76 1.0×	14	714

Countries citing papers authored by Alfredo Rivas‐Delgado

Since Specialization

Citations

This map shows the geographic impact of Alfredo Rivas‐Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Rivas‐Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Rivas‐Delgado more than expected).

Fields of papers citing papers by Alfredo Rivas‐Delgado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Rivas‐Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Rivas‐Delgado. The network helps show where Alfredo Rivas‐Delgado may publish in the future.

Co-authorship network of co-authors of Alfredo Rivas‐Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Rivas‐Delgado. A scholar is included among the top collaborators of Alfredo Rivas‐Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Rivas‐Delgado. Alfredo Rivas‐Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valtis, Yannis K., Roni Shouval, Kai Rejeski, et al.. (2024). Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes. Blood Advances. 9(1). 151–161. 6 indexed citations

Ferrés, Abel, Thomaz E. Topczewski, Andrea Rivero, et al.. (2023). The ghost tumour revisited. Corticosteroids in primary central nervous system lymphoma: diagnostic, prognostic and therapeutic implications. British Journal of Neurosurgery. 39(3). 352–359.

Moreno, David F., Mònica López‐Guerra, Aina Oliver‐Caldés, et al.. (2022). Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia. British Journal of Haematology. 200(2). 187–196. 15 indexed citations

Mozas, Pablo, Andrea Rivero, Alfredo Rivas‐Delgado, et al.. (2021). The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma. Leukemia & lymphoma. 63(4). 903–910. 9 indexed citations

Mozas, Pablo, Andrea Rivero, Alfredo Rivas‐Delgado, et al.. (2021). Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma. Annals of Hematology. 100(5). 1231–1239. 5 indexed citations

Valero, Juan García, Alba Matas‐Céspedes, Fabián Arenas, et al.. (2021). The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma. Leukemia. 35(9). 2635–2649. 52 indexed citations

Rivero, Andrea, Pablo Mozas, Mònica López‐Guerra, et al.. (2021). Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution. Cancers. 13(15). 3900–3900. 12 indexed citations

Mozas, Pablo, Andrea Rivero, Alfredo Rivas‐Delgado, et al.. (2021). Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation. Hematological Oncology. 39(5). 639–649. 5 indexed citations

Mozas, Pablo, Marc Sorigué, Alfredo Rivas‐Delgado, et al.. (2020). The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients. European Journal Of Haematology. 106(3). 428–432. 1 indexed citations

10.

Mozas, Pablo, Alfredo Rivas‐Delgado, Andrea Rivero, et al.. (2020). High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. Leukemia Research. 94. 106371–106371. 11 indexed citations

11.

Mozas, Pablo, Andrea Rivero, Alfredo Rivas‐Delgado, et al.. (2020). A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma. Leukemia & lymphoma. 62(1). 104–111. 6 indexed citations

12.

Mozas, Pablo, Ferran Nadeu, Alfredo Rivas‐Delgado, et al.. (2020). Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience. Blood Cancer Journal. 10(3). 31–31. 25 indexed citations

13.

Rivas‐Delgado, Alfredo, Laura Magnano, Olga García, et al.. (2018). Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era. British Journal of Haematology. 184(5). 753–759. 44 indexed citations

14.

Delgado, Julio, Michael Doubek, Tycho Baumann, et al.. (2017). Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers ( IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. American Journal of Hematology. 92(4). 375–380. 66 indexed citations

15.

Rivas‐Delgado, Alfredo, Laura Magnano, Pablo Mozas, et al.. (2017). Progression‐free survival shortens after each relapse in patients with follicular lymphoma treated in the rituximab era. Hematological Oncology. 35(S2). 360–361. 4 indexed citations

16.

Dlouhy, Iván, Xavier Filella, Jordina Rovira, et al.. (2017). High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma. Leukemia Research. 59. 20–25. 38 indexed citations

17.

Magnano, Laura, Olga Balagué, Iván Dlouhy, et al.. (2017). Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma. Annals of Oncology. 28(11). 2799–2805. 20 indexed citations

18.

Rivas‐Delgado, Alfredo, Estella Matutes, & Marı́a Rozman. (2015). Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection. British Journal of Haematology. 172(4). 495–495. 6 indexed citations

19.

Rivas‐Delgado, Alfredo, Mariana Díaz‐Zamudio, Nicholas Williams, et al.. (2013). Clinical Impact of a 6-Week Preoperative Very Low Calorie Diet on Body Weight and Liver Size in Morbidly Obese Patients. Obesity Surgery. 23(10). 1624–1631. 39 indexed citations

20.

Rivas‐Delgado, Alfredo, et al.. (2009). Evaluación de la calidad de vida en pacientes sometidos a cirugía de obesidad mórbida. El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León). 11(45). 243–246. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact